Insider trading · Q3 2026 · CIK 1811063

Nuvation Bio Inc. (NUVB) insider trading.

In Q3 2026, insiders at Nuvation Bio Inc. reported 4 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $709K.

Transactions
4
Purchases (P)
0
Sales (S)
1
Net shares, P minus S
-100,000
Insiders
2
Last filed
2026-08-21

Insiders

InsiderRelationshipTransactionsBuysSales
Hattersley GaryOfficer · CHIEF SCIENTIFIC OFFICER201
Sauvage PhilippeOfficer · Chief Financial Officer200

Transactions

4 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-08-19Hattersley GaryM (A)100,000$1.87100,000Form 4
2026-08-19Hattersley GaryS (D)100,000$7.090Form 4
2026-07-15Sauvage PhilippeM (A)1$1.9754,131Form 4
2026-07-15Sauvage PhilippeM (A)39,999$2.1754,130Form 4

Transaction codes in this quarter

Get NUVB insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1811063&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · NUVB company page · Nuvation Bio Inc. on SEC.gov

Questions

Are insiders buying or selling Nuvation Bio Inc. (NUVB)?

In Q3 2026, insiders at Nuvation Bio Inc. reported 4 non-derivative transactions on 2 Forms 3, 4 and 5: 0 open-market purchases and 1 sale worth $709K. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Nuvation Bio Inc. insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/nuvb.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.